• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Defensive·DALMIASUG.NS
Share

Dalmia Bharat Sugar and Industries Limited Stocks

₹ 481.4Last Updated 16.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

₹ 365.84M

₹ 481.4
Key Takeaways

Risk factor

Limited trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Slightly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dalmia Bharat Sugar and Industries Limited is an Indian-based corporation with global operations, principally engaged in the sugar industry. Its multifaceted operations are structured across segments encompassing its own manufactured sugar, power generation, distillery activities, and various other businesses. The company produces and distributes a wide range of sugar products, including refined sugar, double sulphitation sugars, and premium offerings like sulfur-free white crystal sugar and natural brown sugar under the 'Dalmia Utsav' brand. By-products from its sugar manufacturing, such as bagasse and molasses, are utilized for generating power. Furthermore, DBSIL is a significant producer and supplier of various alcohols, including rectified spirits, extra neutral alcohol (or hydrous alcohol), denatured spirits, and ethanol (or anhydrous ethanol), along with alcohol-based hand sanitizers sold under the 'Dalmia Sanjeevani' label. The company also extends its manufacturing capabilities to refractory products and contributes to renewable energy, operating co-generation plants with a capacity of 123 MW and wind farms generating 17 MW. Its diverse portfolio also includes ventures in magnesite, travel, and electronics, in addition to the production and sale of organic manure to farmers. Established in 1951, the company maintains its headquarters in New Delhi, India.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of DALMIASUG.NS is 560 and suggests 16.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

18.10.2026 21:01

Anthropic's Valuation Falls, SpaceX Drives the Market: Key Takeaways on IPOs as of October 18

17.10.2026 21:12

DeepSeek unveils updated AI model claimed to be faster than its predecessor

17.10.2026 16:01

Small caps last week: Russell 2000 correction, Bumble sale, Crocs celeb partnerships

17.10.2026 13:01

The Weak Link in the AI Revolution: Big Pharma Comes to the Rescue of Investors; Burry Believes in Mortgages

17.10.2026 03:47

‘All of this is going to pass’: Nvidia CEO is confident AI rally will continue

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026